AstraZeneca
AstraZeneca plc (AZ) is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
Recent news mentioning AstraZeneca
- — Here Are Monday’s Top Wall Street Analyst Research Calls: AstraZeneca, Celestica, Chipotle Mexican Grill, Domino’s Pizza, Fortune Brands, Golar LNG, Jersey Mike’s Subs, Roku, and More
- — AstraZeneca’s Earnings Beat Shows Momentum, But Can its Pipeline Deliver $80 Billion in Revenue?
- — AstraZeneca Made a $1.5 Billion Lung Cancer Bet, but Can Zegfrovy Strengthen its Oncology Growth?
- — AstraZeneca: Pharmakonzern stoppt wichtige Studie zu Lungenkrebs-Mittel
- — Is the Reported $400 Billion AstraZeneca-Bristol Myers Squibb Megamerger a Slam Dunk -- or a Disaster Waiting to Happen?
- — Royalty Pharma plc (RPRX) vs. AstraZeneca PLC (AZN): Which Biopharma Model Offers the Better Growth Story?
- — AstraZeneca PLC (AZN) vs. Bristol-Myers Squibb Company (BMY): Wall Street Doesn’t Buy This Merger Talk
- — Hedge Funds are Bullish on AstraZeneca PLC (AZN)
- — Can AstraZeneca (AZN) Reach Its $80 Billion Revenue Goal Despite Clinical Setbacks?
- — Pascal Soriot, el ‘sir’ que pasó de la ‘banlieue’ a liderar AstraZeneca
- — Deal or No Deal, AstraZeneca Stock Is a Bargain
- — Soriot should explain the curious case of AstraZeneca’s non-deal
Appears alongside
See AstraZeneca's full profile, network and analytical read on Beyond →